Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
October 11, 2012
C. ROBERT KIDDER JOINS BOARD OF DIRECTORS OF WILDCAT DISCOVERY TECHNOLOGIES, INC.
October 4, 2012
ANAPHORE ANNOUNCES NAME CHANGE TO RUIYI AND NEW ADDITIONS TO SHANGHAI MANAGEMENT TEAM
October 4, 2012
RUIYI (FORMERLY ANAPHORE) AND ARGEN-X ANNOUNCE EXCLUSIVE WORLDWIDE LICENSE AGREEMENT FOR ARGX-109, A NOVEL ANTI-IL-6 ANTIBODY
September 26, 2012
WILDCAT DISCOVERY TECHNOLOGIES ENTERS JOINT DEVELOPMENT AGREEMENT WITH JAPAN’S ASAHI KASEI CORP. FOR RECHARGEABLE BATTERY TECHNOLOGY
September 18, 2012
IGENICA APPOINTS MARY HAAK-FRENDSCHO, PH.D., AS CHIEF EXECUTIVE OFFICER
September 14, 2012
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS AND PULMATRIX INITIATE COLLABORATION TO ACCELERATE PUR118 IN THE TREATMENT OF CYSTIC FIBROSIS
September 13, 2012
PEARL THERAPEUTICS COMPLETES PHASE 2B STUDY OF GLYCOPYRROLATE, DEFINES DOSE-RESPONSE CURVE AND IDENTIFIES OPTIMAL DOSE OF PT001
September 7, 2012
BIOTIE HAS COMPLETED A DIRECTED SHARE ISSUE OF EUR 20 MILLION TO INSTITUTIONAL AND STRATEGIC INVESTORS
August 27, 2012
GENOMEWEB/PROTEOMONITOR ARTICLE: NOLAN LAB PROFILES SMALL-MOLECULE INHIBITORS USING NEW MULTIPLEXING METHOD FOR DVS SCIENCES’ CYTOF
August 24, 2012
NOVIRA THERAPEUTICS SECURES $23 MILLION SERIES A FINANCING TO ADVANCE DEVELOPMENT OF ANTIVIRALS FOR TREATMENT OF CHRONIC HEPATITIS B AND HIV INFECTIONS
« Previous Page
1
…
106
107
108
109
110
…
119
Next Page »